Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000650003 | SCV000771840 | benign | Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001719157 | SCV001947548 | benign | not provided | 2021-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002442345 | SCV002734637 | likely benign | Inborn genetic diseases | 2021-01-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV003151117 | SCV003839608 | benign | not specified | 2022-08-26 | no assertion criteria provided | clinical testing |